85 related articles for article (PubMed ID: 33906100)
61. Deterministic linkage for improving follow-up time in a Brazilian population-based cancer registry.
Pereira TF; Aranha VJ; Waldvogel BC; da Costa AM; Tavares Guerreiro Fregnani JH
Sci Rep; 2023 Mar; 13(1):4816. PubMed ID: 36964184
[TBL] [Abstract][Full Text] [Related]
62. Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
Lott BE; Halkiyo A; Kassa DW; Kebede T; Dedefo A; Ehiri J; Madhivanan P; Carvajal S; Soliman A
BMC Womens Health; 2021 May; 21(1):185. PubMed ID: 33941159
[TBL] [Abstract][Full Text] [Related]
63. It's time to re-evaluate cervical Cancer screening after age 65.
Dilley S; Huh W; Blechter B; Rositch AF
Gynecol Oncol; 2021 Jul; 162(1):200-202. PubMed ID: 33926748
[TBL] [Abstract][Full Text] [Related]
64. Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019.
Silva GAE; Damacena GN; Ribeiro CM; Alcantara LLM; Souza Júnior PRB; Szwarcwald CL
Rev Saude Publica; 2023; 57():55. PubMed ID: 37878841
[TBL] [Abstract][Full Text] [Related]
65. Recent changes in trends of mortality from cervical cancer in Southeastern Brazil.
Luizaga CTM; Jardim BC; Wünsch Filho V; Eluf Neto J; Silva GAE
Rev Saude Publica; 2023; 57():25. PubMed ID: 37075421
[TBL] [Abstract][Full Text] [Related]
66. Health litigation and cancer survival in patients treated in the public health system in a large Brazilian city, 2014-2019.
de Castro MSM; da Silva GDM; Figueiredo IVO; de Miranda WD; Magalhães Júnior HM; Dos Santos FP; de Sousa RP
BMC Public Health; 2023 Mar; 23(1):534. PubMed ID: 36944943
[TBL] [Abstract][Full Text] [Related]
67. Cytological screening for cervical cancer prevention.
Denny L
Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):189-96. PubMed ID: 22071306
[TBL] [Abstract][Full Text] [Related]
68. Access to colposcopy in the State of São Paulo, Brazil: probabilistic linkage study of administrative data.
Buss LF; Cury L; Ribeiro CM; Silva GAE; Eluf Neto J
Cad Saude Publica; 2022; 38(1):e00304820. PubMed ID: 35043887
[TBL] [Abstract][Full Text] [Related]
69. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
70. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
71. A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.
Benard VB; Jackson JE; Greek A; Senkomago V; Huh WK; Thomas CC; Richardson LC
Cancer Med; 2021 Jun; 10(12):4127-4137. PubMed ID: 34018674
[TBL] [Abstract][Full Text] [Related]
72. Follow-up of women screened for cervical cancer in São Paulo, Brazil: An analysis of the times to diagnostic investigation and treatment.
Madalena Ribeiro C; Dos Santos Silva I; Eluf Neto J; Pereira Baltar Cury LC; Azevedo E Silva G
Cancer Epidemiol; 2021 Jun; 72():101940. PubMed ID: 33906100
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
